205 related articles for article (PubMed ID: 10373756)
21. 8p11 myeloproliferative syndrome with t(1;8)(q25;p11.2): a case report and review of the literature.
Kim WS; Park SG; Park G; Jang SJ; Moon DS; Kang SH
Acta Haematol; 2015; 133(1):101-5. PubMed ID: 25227135
[TBL] [Abstract][Full Text] [Related]
22. Biphenotypic hematologic malignancy: a case report of the 8p11 myeloproliferative syndrome in a child.
Chen X; Zhang Y; Li Y; Lei P; Zhai Y; Liu L
J Pediatr Hematol Oncol; 2010 Aug; 32(6):501-3. PubMed ID: 20562652
[TBL] [Abstract][Full Text] [Related]
23. PKC412 inhibits the zinc finger 198-fibroblast growth factor receptor 1 fusion tyrosine kinase and is active in treatment of stem cell myeloproliferative disorder.
Chen J; Deangelo DJ; Kutok JL; Williams IR; Lee BH; Wadleigh M; Duclos N; Cohen S; Adelsperger J; Okabe R; Coburn A; Galinsky I; Huntly B; Cohen PS; Meyer T; Fabbro D; Roesel J; Banerji L; Griffin JD; Xiao S; Fletcher JA; Stone RM; Gilliland DG
Proc Natl Acad Sci U S A; 2004 Oct; 101(40):14479-84. PubMed ID: 15448205
[TBL] [Abstract][Full Text] [Related]
24. [Clinical and gene involved of one case of 8p11 myeloproliferative syndrome with ins(13;8)(q12;p11p23)].
Zhou F; Chen S; Chao H; Zhang R; Zhou M; Pan J
Zhonghua Xue Ye Xue Za Zhi; 2015 Apr; 36(4):291-6. PubMed ID: 25916288
[TBL] [Abstract][Full Text] [Related]
25. The t(8;17)(p11;q23) in the 8p11 myeloproliferative syndrome fuses MYO18A to FGFR1.
Walz C; Chase A; Schoch C; Weisser A; Schlegel F; Hochhaus A; Fuchs R; Schmitt-Gräff A; Hehlmann R; Cross NC; Reiter A
Leukemia; 2005 Jun; 19(6):1005-9. PubMed ID: 15800673
[TBL] [Abstract][Full Text] [Related]
26. Chromosome 8p11.2 translocations: prevalence, FISH analysis for FGFR1 and MYST3, and clinicopathologic correlates in a consecutive cohort of 13 cases from a single institution.
Patnaik MM; Gangat N; Knudson RA; Keefe JG; Hanson CA; Pardanani A; Ketterling RP; Tefferi A
Am J Hematol; 2010 Apr; 85(4):238-42. PubMed ID: 20143402
[TBL] [Abstract][Full Text] [Related]
27. Common features of myeloproliferative disorders with t(8;9)(p12;q33) and CEP110-FGFR1 fusion: report of a new case and review of the literature.
Mozziconacci MJ; Carbuccia N; Prebet T; Charbonnier A; Murati A; Vey N; Chaffanet M; Birnbaum D
Leuk Res; 2008 Aug; 32(8):1304-8. PubMed ID: 18096225
[TBL] [Abstract][Full Text] [Related]
28. The t(8;13)(p11;q11-12) rearrangement associated with an atypical myeloproliferative disorder fuses the fibroblast growth factor receptor 1 gene to a novel gene RAMP.
Smedley D; Hamoudi R; Clark J; Warren W; Abdul-Rauf M; Somers G; Venter D; Fagan K; Cooper C; Shipley J
Hum Mol Genet; 1998 Apr; 7(4):637-42. PubMed ID: 9499416
[TBL] [Abstract][Full Text] [Related]
29. 14-3-3 Integrates prosurvival signals mediated by the AKT and MAPK pathways in ZNF198-FGFR1-transformed hematopoietic cells.
Dong S; Kang S; Gu TL; Kardar S; Fu H; Lonial S; Khoury HJ; Khuri F; Chen J
Blood; 2007 Jul; 110(1):360-9. PubMed ID: 17389761
[TBL] [Abstract][Full Text] [Related]
30. t(6;8), t(8;9) and t(8;13) translocations associated with stem cell myeloproliferative disorders have close or identical breakpoints in chromosome region 8p11-12.
Chaffanet M; Popovici C; Leroux D; Jacrot M; Adélaïde J; Dastugue N; Grégoire MJ; Hagemeijer A; Lafage-Pochitaloff M; Birnbaum D; Pébusque MJ
Oncogene; 1998 Feb; 16(7):945-9. PubMed ID: 9484786
[TBL] [Abstract][Full Text] [Related]
31. Functional characterization, localization, and inhibitor sensitivity of the TPR-FGFR1 fusion in 8p11 myeloproliferative syndrome.
Malli T; Buxhofer-Ausch V; Rammer M; Erdel M; Kranewitter W; Rumpold H; Marschon R; Deutschbauer S; Simonitsch-Klupp I; Valent P; Muellner-Ammer K; Sebesta C; Birkner T; Webersinke G
Genes Chromosomes Cancer; 2016 Jan; 55(1):60-8. PubMed ID: 26391436
[TBL] [Abstract][Full Text] [Related]
32. Primary cells in BCR/FGFR1-positive 8p11 myeloproliferative syndrome are sensitive to dovitinib, ponatinib, and dasatinib.
Landberg N; Dreimane A; Rissler M; Billström R; Ågerstam H
Eur J Haematol; 2017 Nov; 99(5):442-448. PubMed ID: 28881484
[TBL] [Abstract][Full Text] [Related]
33. Rapid transformation of atypical myeloproliferative disorder with consistent t(8;13) to B-cell acute lymphoblastic leukemia: a case report.
Sahin F; Sercan Z; Ertan Y; Ocakci S; Ay E; Vural F; Yuksel E; Tombuloglu M; Saydam G
Hematology; 2007 Dec; 12(6):489-92. PubMed ID: 17852454
[TBL] [Abstract][Full Text] [Related]
34. [8p11 myeloproliferative syndrome with CEP110-FGFR1 fusion in a patient].
Chao H; Chen S; Zhou M; Lu X; Zhang X; Pan J; Wu C; Zhang R
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2015 Oct; 32(5):679-82. PubMed ID: 26418991
[TBL] [Abstract][Full Text] [Related]
35. Clonal evolution of 8p11 stem cell syndrome in a 14-year-old Chinese boy: a review of literature of t(8;13) associated myeloproliferative diseases.
Wong WS; Cheng KC; Lau KM; Chan NP; Shing MM; Cheng SH; Chik KW; Li CK; Ng MH
Leuk Res; 2007 Feb; 31(2):235-8. PubMed ID: 16777224
[TBL] [Abstract][Full Text] [Related]
36. [The 8p11 myeloproliferative syndrome: a review of recent literature].
Kirito K
Rinsho Ketsueki; 2019; 60(9):1157-1165. PubMed ID: 31597839
[TBL] [Abstract][Full Text] [Related]
37. B-cell acute lymphoblastic leukemia as evolution of a 8p11 myeloproliferative syndrome with t(8;22)(p11;q11) and BCR-FGFR1 fusion gene.
Baldazzi C; Iacobucci I; Luatti S; Ottaviani E; Marzocchi G; Paolini S; Stacchini M; Papayannidis C; Gamberini C; Martinelli G; Baccarani M; Testoni N
Leuk Res; 2010 Oct; 34(10):e282-5. PubMed ID: 20594995
[No Abstract] [Full Text] [Related]
38. Fusion gene-mediated truncation of RUNX1 as a potential mechanism underlying disease progression in the 8p11 myeloproliferative syndrome.
Agerstam H; Lilljebjörn H; Lassen C; Swedin A; Richter J; Vandenberghe P; Johansson B; Fioretos T
Genes Chromosomes Cancer; 2007 Jul; 46(7):635-43. PubMed ID: 17394134
[TBL] [Abstract][Full Text] [Related]
39. The 8p11 myeloproliferative syndrome: review of literature and an illustrative case report.
Goradia A; Bayerl M; Cornfield D
Int J Clin Exp Pathol; 2008 Jan; 1(5):448-56. PubMed ID: 18787627
[TBL] [Abstract][Full Text] [Related]
40. Modeling the human 8p11-myeloproliferative syndrome in immunodeficient mice.
Agerstam H; Järås M; Andersson A; Johnels P; Hansen N; Lassen C; Rissler M; Gisselsson D; Olofsson T; Richter J; Fan X; Ehinger M; Fioretos T
Blood; 2010 Sep; 116(12):2103-11. PubMed ID: 20554971
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
